Harnessing miRNAs: A Novel Approach to Diagnosis and Treatment of Tuberculosis
Journal of Biochemical and Molecular Toxicology · 2025
DOI: 10.1002/jbt.70119 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Biochemical and Molecular Toxicology, 2025. Verfasst von Ahmed S Doghish und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, Badr University in Cairo (BUC), Badr City, Cairo, Egypt. Hauptthemen laut MEDLINE: MicroRNAs, Tuberculosis, Mycobacterium tuberculosis. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 251 Literaturangaben. Gefördert von: The authors received no specific funding for this work..
Abstract (Originalsprache)
Mycobacterium tuberculosis ( Mtb ) complex, responsible for tuberculosis (TB) infection, continues to be a predominant global cause of mortality due to intricate host‐pathogen interactions that affect disease progression. MicroRNAs (miRNAs), essential posttranscriptional regulators, have become pivotal modulators of these relationships. Recent findings indicate that miRNAs actively regulate immunological responses to Mtb complex by modulating autophagy, apoptosis, and immune cell activities. This has resulted in increased interest in miRNAs as prospective diagnostic indicators for TB, especially in differentiating active infection from latent or inactive stages. Variations in miRNA expression during Mtb infection indicate disease progression and offer insights into the immune response. Furthermore, miRNAs present potential as therapeutic targets in host‐directed therapy (HDT) techniques for TB infection. This work examines the function of miRNAs in TB pathogenesis, with the objective of identifying particular miRNAs that regulate the immune response to the Mtb complex, evaluating their diagnostic value and exploring their therapeutic implications in host‐directed therapy for TB infection. The objective is to enhance comprehension of how miRNAs can facilitate improved diagnosis and treatment of TB.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry, Badr University in Cairo (BUC), Badr City, Cairo, Egypt.
- Biochemistry and Molecular Biology Department, Faculty of Pharmacy (Boys), Al-Azhar University, Nasr City, Cairo, Egypt.
- Biochemistry Department, Faculty of Pharmacy, Heliopolis University, Cairo, Egypt.
- Department of Botany, Biotechnology and Its Application Program, Faculty of Science, Mansoura University, Mansoura, Egypt.
- Biochemistry and Molecular Biology, Theodor Bilharz Research Institute, Giza, Egypt.
- School of Biotechnology, Badr University in Cairo, Badr City, Cairo, Egypt.
ORCID-Profile: Mustafa Ahmed Abdel-Reheim
Förderung
- The authors received no specific funding for this work.
Zitieren
APA
Doghish, A. S., Abulsoud, A. I., Nassar, Y. A., Nasr, S. M., Mohammed, O. A., Abdel-Reheim, M. A., Rizk, N. I., Lutfy, R. H., Abdel Mageed, S. S., Ismail, M. A., Abd-Elhalim, H. M., Awad, F. A., Fayez, S. Z., Elimam, H., & Mansour, R. M. (2025). Harnessing miRNAs: A Novel Approach to Diagnosis and Treatment of Tuberculosis. Journal of Biochemical and Molecular Toxicology. https://doi.org/10.1002/jbt.70119
Vancouver
Doghish AS, Abulsoud AI, Nassar YA, Nasr SM, Mohammed OA, Abdel-Reheim MA, et al. Harnessing miRNAs: A Novel Approach to Diagnosis and Treatment of Tuberculosis. Journal of Biochemical and Molecular Toxicology. 2025. doi:10.1002/jbt.70119
BibTeX
@article{Doghish2025,
author = {Doghish, Ahmed S and Abulsoud, Ahmed I and Nassar, Yara A and Nasr, Sami Mohamed and Mohammed, Osama A and Abdel-Reheim, Mustafa Ahmed and Rizk, Nehal I and Lutfy, Radwa H and Abdel Mageed, Sherif S and Ismail, Menattallah A and Abd-Elhalim, Haytham M and Awad, Farah A and Fayez, Salma Zaki and Elimam, Hanan and Mansour, Reda M},
title = {Harnessing miRNAs: A Novel Approach to Diagnosis and Treatment of Tuberculosis},
journal = {Journal of Biochemical and Molecular Toxicology},
year = {2025},
doi = {10.1002/jbt.70119}
}
EUVIMED